Tim Kutzkey
CIK 1614186 · last filed 2026-05-19
Tim Kutzkey is a corporate insider who has filed 16 SEC Form 4 insider transactions across 2 companies since 2019. The most recent filing, for SRZNW, was dated May 19, 2026. Across all open-market trades the lifetime net is +$33.7M, making them a net buyer over the disclosed history. 96 SEC filings were submitted jointly with PONOI CAPITAL, LP.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
NGM price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Filer Profile
SUITE 500
SAN FRANCISCO, CA 94158
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| Surrozen, Inc./DE (SRZNW) Delisted | Director | 900,292 | $0.00 | $1.4K | $11.98M | 12 | 2026-05-19 |
| NGM BIOPHARMACEUTICALS INC (NGM) Delisted | 10%+ Owner | 11,154,337 | $1.54 | $17.18M | $21.70M | 4 | 2022-05-26 |
Recent Filings
16 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-05-19 | Surrozen, Inc./DE (SRZNW) Delisted | Grant (A) | — | $0 | EDGAR |
| 2026-01-20 | Surrozen, Inc./DE (SRZNW) Delisted | Buy (P) | +32,507 | $641.6K | EDGAR |
| 2026-01-15 | Surrozen, Inc./DE (SRZNW) Delisted | Buy (P) | +17,993 | $357.4K | EDGAR |
| 2026-01-08 | Surrozen, Inc./DE (SRZNW) Delisted | Buy (P) | +15,100 | $300.3K | EDGAR |
| 2025-12-08 | Surrozen, Inc./DE (SRZNW) Delisted | Buy (P) | +36,150 | $694.9K | EDGAR |
| 2025-12-02 | Surrozen, Inc./DE (SRZNW) Delisted | Buy (P) | +315,457 | $3.99M | EDGAR |
| 2025-03-28 | Surrozen, Inc./DE (SRZNW) Delisted | Grant (A) | — | $0 | EDGAR |
| 2024-06-06 | Surrozen, Inc./DE (SRZNW) Delisted | Grant (A) | — | $0 | EDGAR |
| 2024-04-17 | Surrozen, Inc./DE (SRZNW) Delisted | Buy (P) | +193,548 | $3.00M | EDGAR |
| 2024-04-08 | Surrozen, Inc./DE (SRZNW) Delisted | Buy (P) | +193,548 | $3.00M | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.